PREMIUM
AIM IHT
A neuroscience company with exciting potential
Following recent news of a significant acquisition, this developer of digital solutions to assess brain health has issued an encouraging trading update (IHT qualifying)
According to the World Health Organisation, disorders of the brain, such as Alzheimer’s disease, Schizophrenia, Parkinson’s, depression and mental illness, are the world’s primary cause of ill health, resulting in higher costs and more hospitalisations than any other disease group.
Early diagnosis of brain illnesses is desirable as it can help to reduce the costs associated with Alzheimer’s disease and dementia.
Cambridge Cognition Holdings (AIM: COG) is a highly innovative AIM listed digital health technology company,…
Continue reading our content…
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
Register FREE for access to limited content.
- Company and markets insights
- Sponsored content
- Podcasts
Previous article Next article
